Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

A 300 mg monthly pulse of prednisolone effectively and safely treats widespread alopecia areata.

Minoxidil helps hair growth in 63.6% of alopecia patients, with 27.3% having excellent results.

Topical Ruxolitinib may safely treat severe hair loss.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Ruxolitinib helped a man regrow his beard after years of hair loss.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Topical minoxidil can help hair regrowth in alopecia areata patients, but maintaining the growth after stopping treatment is inconsistent.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Yellow dots are common in severe alopecia areata.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

COVID-19 doesn't make alopecia areata worse.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.